$47.75 +0.22 (0.46%) Novo Nordisk Shs Sponsored American DepositReceipt Repr 1 Sh -B- - NYSE

Feb. 27, 2015 | 04:00 PM
Key Statistics
Last Trade: 47.75
Trade Time: Feb 27 04:00 PM Eastern Daylight Time
Change: +0.22 (0.46%)
Prev Close: 47.53
Open: 47.40
Bid: 44.00
Ask: 48.45

Competitors

Ticker Name Volume % Change
CYCC Cyclacel Pharmaceuticals Inc 24.28M +37.62%
PFE Pfizer Inc 24.08M -0.78%
MRK Merck & Co Inc 12.89M -0.71%
HZNP Horizon Pharma PLC 10.65M +7.66%
ABBV AbbVie Inc 8.63M -0.03%

NVO Stock Analysis

Partner Headlines

  1. Successful diabetes drug trial

    IBD | Feb. 20, 2015 | 18:40PM EST
  2. Novo Nordisk Pops On Successful Diabetes Drug Trial

    IBD | Feb. 20, 2015 | 11:42AM EST
  3. Novo Nordisk Announces Positive Phase 2 Trial Results, Shares Spike Higher

    Benzinga | Feb. 20, 2015 | 11:14AM EST
  4. Morning Market Gainers

    Benzinga | Feb. 20, 2015 | 09:46AM EST
  5. Friday #PreMarket Movers: Arista Networks Up, CollabRx Down

    Benzinga | Feb. 20, 2015 | 09:00AM EST
  6. Benzinga's Top #PreMarket Gainers

    Benzinga | Feb. 20, 2015 | 08:15AM EST